Compare VIRC & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIRC | CPIX |
|---|---|---|
| Founded | 1950 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.1M | 92.3M |
| IPO Year | 1995 | 2007 |
| Metric | VIRC | CPIX |
|---|---|---|
| Price | $6.07 | $7.91 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.30 | N/A |
| AVG Volume (30 Days) | 28.1K | ★ 130.2K |
| Earning Date | 04-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $199,652,000.00 | $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $5.16 | $1.85 |
| 52 Week High | $9.07 | $8.45 |
| Indicator | VIRC | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 59.24 |
| Support Level | $6.01 | $5.55 |
| Resistance Level | $6.27 | N/A |
| Average True Range (ATR) | 0.14 | 0.82 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 52.38 | 79.41 |
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.